MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The treatments made by Regeneron and Eli Lilly performed well against earlier variants, but only GlaxoSmithKline’s antibody therapy has stayed… read on > read on >
Losing weight before beginning fertility treatment doesn’t boost the odds that a woman who is obese will have a successful pregnancy, a new study shows. Obesity has been linked with difficulty conceiving, as well as pregnancy complications and loss. Many women who are obese and want to get pregnant are advised to lose weight to… read on > read on >
Some kids might be able to get over their peanut allergy if they start immunotherapy while they’re still toddlers, a major new clinical trial reports. In the trial, a group of 1- to 3-year-olds with severe peanut allergies were safely fed gradually increasing daily doses of a peanut protein flour to help accustom their immune… read on > read on >
If the sound of a dental drill sends shivers up your spine, you’re likely in good company: Finnish researchers say that one of every two adults fear the dentist at least a little, while one in 10 are very afraid. But the researchers added that a local dentistry program has found a novel way to… read on > read on >
Online grocery shopping has skyrocketed during the pandemic, but many websites are making it hard to find nutrition information on products, a new study shows. In the United States, packaged foods are required to have a nutrition facts label, ingredients list and warnings about common food allergens, displayed prominently and legibly. Based on the new… read on > read on >
As air pollution worsens, fruits, flowers and the creatures that pollinate them could pay a price. That’s the takeaway from British researchers who used special equipment to control levels of two common pollutants — diesel exhaust and ozone — in a field of black mustard plants, and then monitored pollinating insects over two summers. “We… read on > read on >
Did you watch your waistline expand during lockdown? You’re not alone. Nearly half of U.S. adults piled on excess pounds during the first year of the pandemic, making a national obesity crisis even worse, a new study shows. “Obesity was an epidemic before the pandemic, and little was known on body weight changes in the… read on > read on >
Two years into the pandemic, coronavirus treatments like monoclonal antibodies and antiviral pills have been approved to treat COVID-19, but it’s hard to keep track of which ones still work, experts say. For example, the monoclonal antibody cocktails are approved for emergency use in treating COVID-19, but some aren’t work against the highly contagious Omicron… read on > read on >
U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds. Both the U.S. Food and Drug Administration and the World Health Organization say ivermectin pills — typically used to treat… read on > read on >
Parents struggling with infant feeding issues may have another reason to persevere: New research ties feeding problems with an increased risk of developmental delays. For the study, the mothers of nearly 3,600 children were surveyed about feeding problems at 18, 24 and 30 months of age, such as gagging, crying during meals or pushing food… read on > read on >
-300x169.jpg)
